Making comprehensive genomic profiling available to patients around the world
The Roche and Foundation Medicine® collaboration
Roche and Foundation Medicine are collaborating to pioneer progress in precision medicine for cancer patients around the world.
As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation, and experience in cancer profiling, together we are:1
- Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
- Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials
Foundation Medicine® Fact2,3
Need more details?
Our dedicated client service team offers assistance throughout the process and our medical team is available to support you with interpretation of the report on request.